MedPath

Bladder Suture in Uterus-Sparing Surgery and Hysterectomy for Placenta Percreta

Completed
Conditions
Sutures
Placenta Percreta
Bladder Injury
Registration Number
NCT06267599
Lead Sponsor
Necmettin Erbakan University
Brief Summary

This study aimed to evaluate the short-term and long-term complications of placenta percreta with bladder invasion. This evaluation focuses on cases where bladder dissection and ACAR-style bladder sutures were applied in cases of placenta percreta with bladder invasion that underwent uterine-sparing surgery or hysterectomy.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
81
Inclusion Criteria
  • Pregnant women
  • Clinical diagnosis of PAS
  • PAS with bladder invasion
Exclusion Criteria
  • Cases with incomplete or inadequate medical records
  • Cases with other types of placental invasion (e.g., placenta accreta, placenta increta),
  • Cases with missing key data points.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Comparison of intraoperative bleeding and complication rates of the two groupsduring operation time

It was observed that the amount of intraoperative bleeding (volume aspirated cc blood), surgical time (minutes), blood transfusion rates (%), and hysterectomy rates(%).

Comparison of complication rate between two groupssix months postoperatively

It was described as long-term bladder dysfunction(Nocturia, Urgency, Stress urinary incontinance, fistula rate (%))

Nocturia: Waking up more than once during the night. Urgency: Sudden, intense urge to urinate followed by an involuntary loss of urine.

Stress urinary incontinance: Happens when physical movement or activity - such as coughing, laughing, sneezing, running or heavy lifting - puts pressure (stress) on your bladder, causing you to leak urine.

Comparison of postoperative bleeding between two groupspostoperative three days,

It was observed that the amount of postoperative bleeding (hemoglobin(g/dL) change, need for blood transfusion Unite)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Cemre Alan

🇹🇷

Konya, Turkey

Cemre Alan
🇹🇷Konya, Turkey

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.